Vaccine Induced HIV Seropositivity/reactivity (VISP/R) among Recipients of Adenovirus Vectored HIV-1 Vaccine Prime/boost Regimens

被引:0
|
作者
Kitandwe, Paul [1 ]
Farah, Bashir [2 ]
Bizimana, Jean [3 ]
Karita, Etienne [3 ]
Mutua, Gaudensia [2 ]
Mpendo, Juliet [1 ]
Omosa-Manyonyi, Gloria [2 ]
Bekker, Linda-Gail [4 ]
Gray, Glenda [5 ]
Baden, Lindsey [6 ]
Lehrman, Jennifer [7 ]
Laufer, Dagna [7 ]
Roman, Francois [8 ]
Barin, Burc [9 ]
Schmidt, Claudia [7 ]
Fast, Patricia [7 ]
Cox, Josephine [7 ]
Priddy, Frances [7 ]
Gelderblom, Huub [7 ]
机构
[1] UVRI IAVI HIV Vaccine Program, Entebbe, Uganda
[2] Kenya AIDS Vaccine Initiat, Nairobi, Kenya
[3] Project San Francisco, Kigali, Rwanda
[4] Desmond Tutu HIV Ctr, Cape Town, South Africa
[5] Perinatal HIV Res Unit, Soweto, South Africa
[6] Brigham & Womens Hosp, Div Infect Dis, Boston, MA 02115 USA
[7] Int AIDS Vaccine Initiat IAVI, New York, NY USA
[8] GlaxoSmithKline Vaccines, Rixensart, Belgium
[9] EMMES Corp, Rockville, MD USA
关键词
D O I
暂无
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
P25.12
引用
收藏
页码:394 / 394
页数:1
相关论文
共 50 条
  • [1] Vaccine-Induced HIV Seropositivity/Reactivity in Noninfected HIV Vaccine Recipients
    Cooper, Cristine J.
    Metch, Barbara
    Dragavon, Joan
    Coombs, Robert W.
    Baden, Lindsey R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 304 (03): : 275 - 283
  • [2] Preexisting Adenovirus Seropositivity Is Not Associated With Increased HIV-1 Acquisition in Three HIV-1 Vaccine Efficacy Trials
    Stephenson, Kathryn E.
    Hural, John
    Buchbinder, Susan P.
    Sinangil, Faruk
    Barouch, Dan H.
    JOURNAL OF INFECTIOUS DISEASES, 2012, 205 (12): : 1806 - 1810
  • [3] HIV Vaccine Trials Network (HVTN) 910: Long-term Follow-up of HIV Vaccine-induced Seropositivity (VISP) among HIV Vaccinees
    Hural, John
    Metch, Barbara
    Grunenberg, Nicole
    Allen, Mary
    Coombs, Robert
    Dragavon, Joan
    Puren, Adrian
    Singh, Beverly
    Maenza, Janine
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2016, 32 : 101 - 101
  • [4] Prime-boost immunization with poxvirus or adenovirus vectors as a strategy to develop a protective vaccine for HIV-1
    Paris, Robert M.
    Kim, Jerome H.
    Robb, Merlin L.
    Michael, Nelson L.
    EXPERT REVIEW OF VACCINES, 2010, 9 (09) : 1055 - 1069
  • [5] Novel prime-boost vaccine strategies against HIV-1
    Excler, Jean-Louis
    Kim, Jerome H.
    EXPERT REVIEW OF VACCINES, 2019, 18 (08) : 765 - 779
  • [6] Human immunodeficiency virus (HIV) seropositivity among uninfected HIV vaccine recipients
    Ackers, ML
    Parekh, B
    Evans, TG
    Berman, P
    Phillips, S
    Allen, M
    McDougal, JS
    JOURNAL OF INFECTIOUS DISEASES, 2003, 187 (06): : 879 - 886
  • [7] Replicating adenovirus vector prime/protein boost strategies for HIV vaccine development
    Patterson, L. Jean
    Robert-Guroff, Marjorie
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2008, 8 (09) : 1347 - 1363
  • [8] Assessment of an LSDV-Vectored Vaccine for Heterologous Prime-Boost Immunizations against HIV
    Chapman, Ros
    van Diepen, Michiel
    Douglass, Nicola
    Galant, Shireen
    Jaffer, Mohamed
    Margolin, Emmanuel
    Ximba, Phindile
    Hermanus, Tandile
    Moore, Penny L.
    Williamson, Anna-Lise
    VACCINES, 2021, 9 (11)
  • [9] HIV Seroconversion without Infection after Receipt of Adenovirus-Vectored HIV Type 1 Vaccine
    Quirk, Erin K.
    Mogg, Robin
    Brown, Deborah D.
    Lally, Michelle A.
    Mehrotra, Devan V.
    DiNubile, Mark J.
    Robertson, Michael N.
    CLINICAL INFECTIOUS DISEASES, 2008, 47 (12) : 1593 - 1599
  • [10] Persistence of Vaccine-Induced Antibodies Following HIV-1 DNA Prime MVA Boost Vaccination Among Healthy Tanzanian Volunteers
    Aboud, S.
    Munseri, P.
    Joachim, A.
    Bakari, M.
    Nilsson, C.
    Buma, D.
    Aris, E. A.
    Eligius, L. F.
    Andreas, B.
    Robb, M.
    Marovich, M.
    Michael, N.
    Wahren, B.
    Biberfeld, G.
    Mhalu, F.
    Sandstrom, E.
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 2011, 27 (10) : A75 - A75